FATHEREE, Paul R.,JACOBSEN, John R.,BEAUSOLEIL, Anne-Marie,BRANDT, Gary E.L.,FLEURY, Melissa,JIANG, Lan,SMITH, Cameron,SULLIVAN, Steven D.E.,VAN ORDEN, Lori Jean,COLSON, Pierre-Jean,FASS, Gene Timothy
申请号：
HK18111992
公开号：
HK1252685A1
申请日:
2018.09.18
申请国别(地区):
HK
年份:
2019
代理人:
摘要：
and the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are useful as JAK kinase inhibitors. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat respiratory diseases, and processes and intermediates useful for preparing such compounds.
